370 related articles for article (PubMed ID: 11210069)
1. Relationship between crevicular aspartate aminotransferase levels and periodontal disease progression.
Oringer RJ; Howell TH; Nevins ML; Reasner DS; Davis GH; Sekler J; Fiorellini JP
J Periodontol; 2001 Jan; 72(1):17-24. PubMed ID: 11210069
[TBL] [Abstract][Full Text] [Related]
2. Aspartate aminotransferase levels in gingival crevicular fluid before and after initial periodontal treatment.
Tsalikis L; Malaka E; Pavlitou E; Konstantinidis A
J Int Acad Periodontol; 2001 Jul; 3(3):68-74. PubMed ID: 12666944
[TBL] [Abstract][Full Text] [Related]
3. Gingival crevicular fluid alkaline phosphatase activity reflects periodontal healing/recurrent inflammation phases in chronic periodontitis patients.
Perinetti G; Paolantonio M; Femminella B; Serra E; Spoto G
J Periodontol; 2008 Jul; 79(7):1200-7. PubMed ID: 18597602
[TBL] [Abstract][Full Text] [Related]
4. Relationship of the subgingival microbiota to a chairside test for aspartate aminotransferase in gingival crevicular fluid.
Wong MY; Lu CL; Liu CM; Hou LT; Chang WK
J Periodontol; 1999 Jan; 70(1):57-62. PubMed ID: 10052771
[TBL] [Abstract][Full Text] [Related]
5. Effect of locally delivered minocycline microspheres on markers of bone resorption.
Oringer RJ; Al-Shammari KF; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Berwald B; Nejat R; Giannobile WV
J Periodontol; 2002 Aug; 73(8):835-42. PubMed ID: 12211491
[TBL] [Abstract][Full Text] [Related]
6. [Gingival crevicular aspartate aminotransferase levels in periodontitis patients before and after periodontal treatment].
Li R
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar; 27(2):70-3, 127. PubMed ID: 1288991
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation of aspartate aminotransferase in the crevicular fluid of implants with bone loss and signs of progressive disease.
Rühling A; Jepsen S; Kocher T; Plagmann HC
Int J Oral Maxillofac Implants; 1999; 14(3):428-35. PubMed ID: 10379118
[TBL] [Abstract][Full Text] [Related]
8. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
[TBL] [Abstract][Full Text] [Related]
9. Neutral proteases in crevicular fluid as an indicator for periodontal treatment intervention.
Bader HI; Boyd RL
Am J Dent; 2001 Oct; 14(5):314-8. PubMed ID: 11803997
[TBL] [Abstract][Full Text] [Related]
10. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis.
Erdemir EO; Duran I; Haliloglu S
J Clin Periodontol; 2004 Feb; 31(2):99-104. PubMed ID: 15016034
[TBL] [Abstract][Full Text] [Related]
11. A multi-center clinical trial of a new chairside test in distinguishing between diseased and healthy periodontal sites. II. Association between site type and test outcome before and after therapy.
Magnusson I; Persson RG; Page RC; DeRouen TA; Crawford JM; Cohen RL; Chambers DA; Alves ME; Clark WB
J Periodontol; 1996 Jun; 67(6):589-96. PubMed ID: 8794969
[TBL] [Abstract][Full Text] [Related]
12. Prediction and diagnosis of attachment loss by enhanced chemiluminescent assay of crevicular fluid alkaline phosphatase levels.
Chapple IL; Garner I; Saxby MS; Moscrop H; Matthews JB
J Clin Periodontol; 1999 Mar; 26(3):190-8. PubMed ID: 10100046
[TBL] [Abstract][Full Text] [Related]
13. Relationship between gingival crevicular fluid levels of aspartate aminotransferase and active tissue destruction in treated chronic periodontitis patients.
Persson GR; DeRouen TA; Page RC
J Periodontal Res; 1990 Mar; 25(2):81-7. PubMed ID: 2139121
[TBL] [Abstract][Full Text] [Related]
14. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients.
Nakamura T; Kido J; Kido R; Ohishi K; Yamauchi N; Kataoka M; Nagata T
J Periodontol; 2000 Mar; 71(3):361-7. PubMed ID: 10776922
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis.
Alpagot T; Bell C; Lundergan W; Chambers DW; Rudin R
J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
17. Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels.
Al-Shammari KF; Giannobile WV; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Oringer RJ
J Periodontol; 2001 Aug; 72(8):1045-51. PubMed ID: 11525436
[TBL] [Abstract][Full Text] [Related]
18. A multicenter clinical trial of PerioGard in distinguishing between diseased and healthy periodontal sites. (I). Study design, methodology and therapeutic outcome.
Persson GR; Alves ME; Chambers DA; Clark WB; Cohen R; Crawford JM; DeRouen TA; Magnusson I; Schindler T; Page RC
J Clin Periodontol; 1995 Oct; 22(10):794-803. PubMed ID: 8682927
[TBL] [Abstract][Full Text] [Related]
19. Gingival crevicular fluid levels of aspartate amino transferase, sulfide ions and N-benzoyl-DL-arginine-2-naphthylamide in diabetic patients with chronic periodontitis.
Yucekal-Tuncer B; Uygur C; Firatli E
J Clin Periodontol; 2003 Dec; 30(12):1053-60. PubMed ID: 15002891
[TBL] [Abstract][Full Text] [Related]
20. Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment.
Bhide VM; Smith L; Overall CM; Birek P; McCulloch CA
J Periodontol; 2000 May; 71(5):690-700. PubMed ID: 10872948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
